Vagus Nerve Stimulation Effective in Resistant DepressionVagus Nerve Stimulation Effective in Resistant Depression
Neuroimaging studies show that the brains of people with treatment-resistant depression show altered metabolic activity in areas known to be linked to depression early after vagus nerve stimulation. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 17, 2013 Category: Psychiatry Tags: Psychiatry News Source Type: news

Brain Function Altered By Nerve Stimulation For Severe Depression
For nearly a decade, doctors have used an implanted electronic stimulator to treat severe depression in people who don't respond to standard antidepressant therapy. Now, preliminary brain scan studies conducted by researchers at Washington University School of Medicine in St. Louis are beginning to reveal the processes occurring in the brain during stimulation and may provide some clues about how the device improves depression. They found that vagus nerve stimulation brings about changes in brain metabolism weeks or even months before patients begin to feel better... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 10, 2013 Category: Consumer Health News Tags: Depression Source Type: news

Nerve stimulation for severe depression changes brain function
(Washington University School of Medicine) For nearly a decade, doctors have used implanted electronic stimulators to treat severe depression in people who don't respond to standard antidepressant treatments. Now, preliminary brain scan studies conducted by School of Medicine researchers are revealing that vagus nerve stimulation brings about changes in brain metabolism weeks or even months before patients begin to feel better. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 7, 2013 Category: Global & Universal Source Type: news

Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
OUSTON, Jan. 9, 2013 (HSMN NewsFeed) -- Cyberonics, Inc. (CYBX) today announced that Bruce H. KenKnight, Ph.D., joined the company as its Vice President, Emerging Therapies, effective on January 1, 2013. Dr. KenKnight will lead all of the company's emer... Devices, Neurology, PersonnelCyberonics, VNS Therapy, neuromodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2013 Category: Pharmaceuticals Source Type: news